Poietis (Poietis Biosystems)

Company Snapshot

Founded: 2014
Entity Type: Private
Region: France
Headquarter: Pessac, France
Key Geographics: Europe
Corporate Address: Bordeaux Metropole, Building C – 1st floor, 27 allée Charles Darwin, 33600 Pessac France Tel.: +33-(0)-535-544-728 Web.: www.poietis.com

Company Overview

Poietis, a promising biotech firm spun out of renowned academic institutions - INSERM and the University of Bordeaux, is at the forefront of next-generation bioprinting. With a robust patent portfolio and a talented team of scientists and engineers, it is poised to revolutionize tissue engineering and regenerative medicine. Its innovative platform has the potential to create functional tissues for a wide range of applications, offering hope to countless patients.

Poietis (Poietis Biosystems) In Reports

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

BCC Research Market Analyst says global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029.

3D Cell Cultures: Technologies and Global Markets

BCC Research Market Report says global market for cell culture should grow from $10.3 billion in 2020 to $14.8 billion by 2025, at a compound annual growth rate of 7.5%.

Current Bioprinting Prospects and Future Innovations

Get the comprehensive analysis of the bioprinting technologies and their trending applications in the market at a global scale and five-year CAGRs by segment.

Company's Business Segments

  • 4D Bioprinting Technology : The company develop and manufacture human tissues by using 4D bioprinting. It also offers Next Generation Bioprinting (NGB) systems for both research and clinical applications, focusing on creating 3D tissue models and advanced therapies.

Applications/End User Industries

  • Pharmaceuticals
  • Cosmetics
  • Hospitals
  • Research Institutions
  • Healthcare
  • Life Sciences
AI Sentiment